Biologics Market: Is 2026 the Year "Sustainable Bioprocessing" Becomes a Regulatory Mandate The 2026 Biologics Market is going "Green." As global environmental regulations tighten, 2026 has become the year of "Sustainable Bioproduction," where the "Carbon Footprint" of a drug is as scrutinized as its clinical efficacy. The 2026 market is seeing a massive shift toward "Single-Use Bioreactors," which now hold a 61.8% share of the manufacturing segment. These 2026 systems eliminate the...
0 แชร์
674 ยอดวิว
0 รีวิว